Knockdown of LncRNA DICER1-AS1 arrests the cell cycle, inhibits cell proliferation, and induces cell apoptosis by regulating CDC5L nuclear transfer in osteosarcoma
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Knockdown of LncRNA DICER1-AS1 arrests the cell cycle, inhibits cell proliferation, and induces cell apoptosis by regulating CDC5L nuclear transfer in osteosarcoma
Authors
Keywords
-
Journal
CONNECTIVE TISSUE RESEARCH
Volume -, Issue -, Pages 1-13
Publisher
Informa UK Limited
Online
2023-06-13
DOI
10.1080/03008207.2023.2223289
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A reciprocal feedback between N6-methyladenosine reader YTHDF3 and lncRNA DICER1-AS1 promotes glycolysis of pancreatic cancer through inhibiting maturation of miR-5586-5p
- (2022) Yuhang Hu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Long non-coding RNA DICER1-AS1-low expression in arsenic-treated A549 cells inhibits cell proliferation by regulating the cell cycle pathway
- (2021) Chenglan Jiang et al. ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
- CDC5L promotes early chondrocyte differentiation and proliferation by modulating pre-mRNA splicing of SOX9, COL2A1, and WEE1
- (2021) Go Jokoji et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Advancing therapy for osteosarcoma
- (2021) Jonathan Gill et al. Nature Reviews Clinical Oncology
- Osteosarcoma mechanobiology and therapeutic targets
- (2021) Zunaira Shoaib et al. BRITISH JOURNAL OF PHARMACOLOGY
- Circ‐PGAM1 promotes malignant progression of epithelial ovarian cancer through regulation of the miR‐542‐3p/CDC5L/PEAK1 pathway
- (2020) Chunmei Zhang et al. Cancer Medicine
- ANXA7 promotes the cell cycle, proliferation and cell adhesion-mediated drug resistance of multiple myeloma cells by up-regulating CDC5L
- (2020) Haiyan Liu et al. Aging-US
- Long non‑coding RNA PCAT6 promotes the development of osteosarcoma by increasing MDM2 expression
- (2020) Xiliang Guan et al. ONCOLOGY REPORTS
- New insights into molecular and cellular mechanisms of zoledronate in human osteosarcoma
- (2020) Ko-Hsiu Lu et al. PHARMACOLOGY & THERAPEUTICS
- DICER1-AS1 Promotes the Malignant Behaviors of Colorectal Cancer Cells by Regulating miR-296-5p/STAT3 Axis
- (2020) Chuanyu Ma et al. Cancer Management and Research
- PTEN in osteosarcoma: Recent advances and the therapeutic potential
- (2020) Chuanxi Zheng et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Long Noncoding RNA LINC00963 Promotes CDC5L-Mediated Malignant Progression in Gastric Cancer
- (2020) Hong Zhu et al. OncoTargets and Therapy
- Immunotherapy for osteosarcoma: Fundamental mechanism, rationale, and recent breakthroughs
- (2020) Chenglong Chen et al. CANCER LETTERS
- Noncoding RNAs as circulating biomarkers in osteosarcoma patients
- (2019) Gerardo Botti et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Advances in differentiation therapy for osteosarcoma
- (2019) Yingqian Chen et al. DRUG DISCOVERY TODAY
- LncRNA DICER1-AS1 promotes the proliferation, invasion and autophagy of osteosarcoma cells via miR-30b/ATG5
- (2018) Zenghui Gu et al. BIOMEDICINE & PHARMACOTHERAPY
- Oncogenic properties of NEAT1 in prostate cancer cells depend on the CDC5L-AGRN transcriptional regulation circuit
- (2018) Xin Li et al. CANCER RESEARCH
- Osteosarcoma, Chondrosarcoma, and Chordoma
- (2018) Jeremy S. Whelan et al. JOURNAL OF CLINICAL ONCOLOGY
- The lncRNA MACC1-AS1 promotes gastric cancer cell metabolic plasticity via AMPK/Lin28 mediated mRNA stability of MACC1
- (2018) Yang Zhao et al. Molecular Cancer
- Prp19 Arrests Cell Cycle via Cdc5L in Hepatocellular Carcinoma Cells
- (2017) Renzheng Huang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Expression and Clinical Role of Cdc5L as a Novel Cell Cycle Protein in Hepatocellular Carcinoma
- (2015) Huiyuan Qiu et al. DIGESTIVE DISEASES AND SCIENCES
- RETRACTED ARTICLE: Evaluation of gene expression level of CDC5L and MACC1 in poor prognosis and progression of osteosarcoma
- (2015) Mohsen Mohammadi et al. TUMOR BIOLOGY
- Digital Expression Profiling Identifies RUNX2, CDC5L, MDM2, RECQL4, and CDK4 as Potential Predictive Biomarkers for Neo-Adjuvant Chemotherapy Response in Paediatric Osteosarcoma
- (2014) Jeffrey W. Martin et al. PLoS One
- Depletion of pre-mRNA splicing factor Cdc5L inhibits mitotic progression and triggers mitotic catastrophe
- (2014) R Mu et al. Cell Death & Disease
- Cell Cycle Regulator Gene CDC5L, a Potential Target for 6p12-p21 Amplicon in Osteosarcoma
- (2008) X.-Y. Lu et al. MOLECULAR CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started